MUMBAI -- Indian health care startup Niramai Health Analytix is in talks with Asian hospitals for its noninvasive, artificial intelligence-enabled technology to screen for early signs of breast cancer.
The startup has raised about $7 million from Japan's Dream Incubator and local investors Pi Ventures, Axilor and Flipkart co-founder Binny Bansal, among others. It is now preparing pretrials in South and Southeast Asian countries with a high incidence of breast cancer.
.jpg?width=178&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms&format=auto&height=100)
.jpg?width=178&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms&format=auto&height=100)